SLE, systemic lupus erythematosus

The binding of lupus-derived autoantibodies to the C-terminal peptide (83–119) of the major SmD1 autoantigen can be mediated by double-stranded DNA and nucleosomes
J W Dieker, C C Van Bavel, G Riemekasten, J H Berden, J van der Vlag

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1525-1528; DOI: 10.1136/ard.2005.043992
High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors
Cecilia P Chung, Ingrid Avalos, Annette Oeser, Tebeb Gebretsadik, Ayumi Shintani, Paolo Raggi, C Michael Stein

Annals of the Rheumatic Diseases Feb 2007, 66 (2) 208-214; DOI: 10.1136/ard.2006.054973
Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production
Frédéric Lavie, Corinne Miceli-Richard, Marc Ittah, Jérémie Sellam, Jacques-Eric Gottenberg, Xavier Mariette

Annals of the Rheumatic Diseases May 2007, 66 (5) 700-702; DOI: 10.1136/ard.2006.060772
Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis
M H Schiff, G R Burmester, J D Kent, A L Pangan, H Kupper, S B Fitzpatrick, C Donovan

Annals of the Rheumatic Diseases Jul 2006, 65 (7) 889-894; DOI: 10.1136/ard.2005.043166
Ethnic and geographical variation in antiphospholipid (Hughes) syndrome
I Uthman, M Khamashta

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1671-1676; DOI: 10.1136/ard.2005.038448
Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: a quality improvement study
M B Urowitz, D D Gladman, D Ibanez, Y Berliner

Annals of the Rheumatic Diseases Jan 2006, 65 (1) 115-117; DOI: 10.1136/ard.2005.038802
Antimalarials may influence the risk of malignancy in systemic lupus erythematosus
G Ruiz-Irastorza, A Ugarte, M V Egurbide, M Garmendia, J I Pijoan, A Martinez-Berriotxoa, C Aguirre

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 815-817; DOI: 10.1136/ard.2006.067777
How to monitor SLE in routine clinical practice
M M A Fernando, D A Isenberg

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 524-527; DOI: 10.1136/ard.2003.015248
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome
R Cervera, J Font, J A Gómez-Puerta, G Espinosa, M Cucho, S Bucciarelli, M Ramos-Casals, M Ingelmo, J-C Piette, Y Shoenfeld, R A Asherson

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1205-1209; DOI: 10.1136/ard.2004.025759
Enrichment of CD4+ CD25^high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids
A Suárez, P López, J Gómez, C Gutiérrez

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1512-1517; DOI: 10.1136/ard.2005.049924

Main menu

SLE, systemic lupus erythematosus

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

SLE, systemic lupus erythematosus

Pages